155 related articles for article (PubMed ID: 30368947)
1. Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study.
Wästerlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
J Intern Med; 2019 Apr; 285(4):455-468. PubMed ID: 30368947
[TBL] [Abstract][Full Text] [Related]
2. Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study.
Sonnevi K; Wästerlid T; Melén CM; Harrysson S; Smedby KE; Wahlin BE
Br J Haematol; 2021 Jan; 192(1):75-81. PubMed ID: 32400004
[TBL] [Abstract][Full Text] [Related]
3. Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.
Székely E; Lindén O; Peterson S; Jerkeman M
Eur J Haematol; 2016 Oct; 97(4):393-8. PubMed ID: 26872557
[TBL] [Abstract][Full Text] [Related]
4. Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities.
Antic D; Jelicic J; Trajkovic G; Balint MT; Bila J; Markovic O; Petkovic I; Nikolic V; Andjelic B; Djurasinovic V; Sretenovic A; Smiljanic M; Vukovic V; Mihaljevic B
Ann Hematol; 2018 Feb; 97(2):267-276. PubMed ID: 29130134
[TBL] [Abstract][Full Text] [Related]
5. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
[TBL] [Abstract][Full Text] [Related]
6. Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study.
Ellin F; Jerkeman M; Törnqvist J; Brudin L; Relander T
Hematol Oncol; 2018 Feb; 36(1):159-165. PubMed ID: 28474339
[TBL] [Abstract][Full Text] [Related]
7. Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects.
Smyth L; Blunt DN; Gatov E; Nagamuthu C; Croxford R; Mozessohn L; Cheung MC
Br J Haematol; 2020 Nov; 191(3):396-404. PubMed ID: 32304100
[TBL] [Abstract][Full Text] [Related]
8. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
Howlader N; Mariotto AB; Besson C; Suneja G; Robien K; Younes N; Engels EA
Cancer; 2017 Sep; 123(17):3326-3334. PubMed ID: 28464214
[TBL] [Abstract][Full Text] [Related]
9. Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.
El-Galaly TC; Jakobsen LH; Hutchings M; de Nully Brown P; Nilsson-Ehle H; Székely E; Mylam KJ; Hjalmar V; Johnsen HE; Bøgsted M; Jerkeman M
J Clin Oncol; 2015 Dec; 33(34):3993-8. PubMed ID: 26438115
[TBL] [Abstract][Full Text] [Related]
10. The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma.
Lin TL; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Tang TC; Chang H; Hung YS
Ann Hematol; 2012 Sep; 91(9):1383-91. PubMed ID: 22526364
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study.
Wieringa A; Boslooper K; Hoogendoorn M; Joosten P; Beerden T; Storm H; Kibbelaar RE; Veldhuis GJ; van Kamp H; van Rees B; Kluin-Nelemans HC; Veeger NJ; van Roon EN
Br J Haematol; 2014 May; 165(4):489-96. PubMed ID: 24754632
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma.
Saglam B; Albayrak M; Yıldız A; Tığlıoğlu P; Tığlıoğlu M; Aras MR; Yilmaz F; Maral S; A Öztürk HB
Niger J Clin Pract; 2023 Oct; 26(10):1512-1518. PubMed ID: 37929528
[TBL] [Abstract][Full Text] [Related]
14. Improvement in survival of diffuse large B-cell lymphoma in relation to age, gender, International Prognostic Index and extranodal presentation: a population based Swedish Lymphoma Registry study.
Székely E; Hagberg O; Arnljots K; Jerkeman M
Leuk Lymphoma; 2014 Aug; 55(8):1838-43. PubMed ID: 24138330
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
Griffiths R; Gleeson M; Knopf K; Danese M
BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
[TBL] [Abstract][Full Text] [Related]
16. Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
Mörth C; Valachis A; Sabaa AA; Molin D; Flogegård M; Enblad G
Ann Hematol; 2018 Nov; 97(11):2129-2135. PubMed ID: 30091025
[TBL] [Abstract][Full Text] [Related]
17. A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.
Miura K; Konishi J; Miyake T; Makita M; Hojo A; Masaki Y; Uno M; Ozaki J; Yoshida C; Niiya D; Kitazume K; Maeda Y; Takizawa J; Sakai R; Yano T; Yamamoto K; Sunami K; Hiramatsu Y; Aoyama K; Tsujimura H; Murakami J; Hatta Y; Kanno M
Oncologist; 2017 May; 22(5):554-560. PubMed ID: 28408622
[TBL] [Abstract][Full Text] [Related]
18. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
19. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
[TBL] [Abstract][Full Text] [Related]
20. Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study.
Hedström G; Peterson S; Berglund M; Jerkeman M; Enblad G;
Acta Oncol; 2015 Jun; 54(6):924-32. PubMed ID: 25843161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
